Crossref
Letter regarding Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
Journal of Psoriasis and Psoriatic Arthritis · 2016
DOI: 10.1177/247553031600100201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Psoriasis and Psoriatic Arthritis, 2016. Verfasst von Jashin J. Wu. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Wu, J. J. (2016). Letter regarding Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis. Journal of Psoriasis and Psoriatic Arthritis. https://doi.org/10.1177/247553031600100201
Vancouver
Wu JJ. Letter regarding Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis. Journal of Psoriasis and Psoriatic Arthritis. 2016. doi:10.1177/247553031600100201
BibTeX
@article{Wu2016,
author = {Wu, Jashin J.},
title = {Letter regarding Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis},
journal = {Journal of Psoriasis and Psoriatic Arthritis},
year = {2016},
doi = {10.1177/247553031600100201}
}
EUVIMED